Copyright Reports & Markets. All rights reserved.

Global Percutaneous Coronary Intervention Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Percutaneous Coronary Intervention Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Drug-Eluting Stents
      • 1.4.3 Bare Metal Stents
      • 1.4.4 Bioresorbable Stents
    • 1.5 Market by Application
      • 1.5.1 Global Percutaneous Coronary Intervention Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Healthcare Centers
      • 1.5.4 Neurological Research Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Percutaneous Coronary Intervention Market Size
    • 2.2 Percutaneous Coronary Intervention Growth Trends by Regions
      • 2.2.1 Percutaneous Coronary Intervention Market Size by Regions (2014-2025)
      • 2.2.2 Percutaneous Coronary Intervention Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Percutaneous Coronary Intervention Market Size by Manufacturers
      • 3.1.1 Global Percutaneous Coronary Intervention Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Percutaneous Coronary Intervention Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Percutaneous Coronary Intervention Market Concentration Ratio (CR5 and HHI)
    • 3.2 Percutaneous Coronary Intervention Key Players Head office and Area Served
    • 3.3 Key Players Percutaneous Coronary Intervention Product/Solution/Service
    • 3.4 Date of Enter into Percutaneous Coronary Intervention Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Percutaneous Coronary Intervention Market Size by Type (2014-2019)
    • 4.2 Global Percutaneous Coronary Intervention Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Percutaneous Coronary Intervention Market Size (2014-2019)
    • 5.2 Percutaneous Coronary Intervention Key Players in United States
    • 5.3 United States Percutaneous Coronary Intervention Market Size by Type
    • 5.4 United States Percutaneous Coronary Intervention Market Size by Application

    6 Europe

    • 6.1 Europe Percutaneous Coronary Intervention Market Size (2014-2019)
    • 6.2 Percutaneous Coronary Intervention Key Players in Europe
    • 6.3 Europe Percutaneous Coronary Intervention Market Size by Type
    • 6.4 Europe Percutaneous Coronary Intervention Market Size by Application

    7 China

    • 7.1 China Percutaneous Coronary Intervention Market Size (2014-2019)
    • 7.2 Percutaneous Coronary Intervention Key Players in China
    • 7.3 China Percutaneous Coronary Intervention Market Size by Type
    • 7.4 China Percutaneous Coronary Intervention Market Size by Application

    8 Japan

    • 8.1 Japan Percutaneous Coronary Intervention Market Size (2014-2019)
    • 8.2 Percutaneous Coronary Intervention Key Players in Japan
    • 8.3 Japan Percutaneous Coronary Intervention Market Size by Type
    • 8.4 Japan Percutaneous Coronary Intervention Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Percutaneous Coronary Intervention Market Size (2014-2019)
    • 9.2 Percutaneous Coronary Intervention Key Players in Southeast Asia
    • 9.3 Southeast Asia Percutaneous Coronary Intervention Market Size by Type
    • 9.4 Southeast Asia Percutaneous Coronary Intervention Market Size by Application

    10 India

    • 10.1 India Percutaneous Coronary Intervention Market Size (2014-2019)
    • 10.2 Percutaneous Coronary Intervention Key Players in India
    • 10.3 India Percutaneous Coronary Intervention Market Size by Type
    • 10.4 India Percutaneous Coronary Intervention Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Percutaneous Coronary Intervention Market Size (2014-2019)
    • 11.2 Percutaneous Coronary Intervention Key Players in Central & South America
    • 11.3 Central & South America Percutaneous Coronary Intervention Market Size by Type
    • 11.4 Central & South America Percutaneous Coronary Intervention Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott Vascular
      • 12.1.1 Abbott Vascular Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Percutaneous Coronary Intervention Introduction
      • 12.1.4 Abbott Vascular Revenue in Percutaneous Coronary Intervention Business (2014-2019)
      • 12.1.5 Abbott Vascular Recent Development
    • 12.2 Svelte Medical
      • 12.2.1 Svelte Medical Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Percutaneous Coronary Intervention Introduction
      • 12.2.4 Svelte Medical Revenue in Percutaneous Coronary Intervention Business (2014-2019)
      • 12.2.5 Svelte Medical Recent Development
    • 12.3 Medtronic
      • 12.3.1 Medtronic Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Percutaneous Coronary Intervention Introduction
      • 12.3.4 Medtronic Revenue in Percutaneous Coronary Intervention Business (2014-2019)
      • 12.3.5 Medtronic Recent Development
    • 12.4 Boston Scientific
      • 12.4.1 Boston Scientific Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Percutaneous Coronary Intervention Introduction
      • 12.4.4 Boston Scientific Revenue in Percutaneous Coronary Intervention Business (2014-2019)
      • 12.4.5 Boston Scientific Recent Development
    • 12.5 Sysmetis
      • 12.5.1 Sysmetis Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Percutaneous Coronary Intervention Introduction
      • 12.5.4 Sysmetis Revenue in Percutaneous Coronary Intervention Business (2014-2019)
      • 12.5.5 Sysmetis Recent Development
    • 12.6 Cardiac Dimensions
      • 12.6.1 Cardiac Dimensions Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Percutaneous Coronary Intervention Introduction
      • 12.6.4 Cardiac Dimensions Revenue in Percutaneous Coronary Intervention Business (2014-2019)
      • 12.6.5 Cardiac Dimensions Recent Development
    • 12.7 Edwards Lifesciences
      • 12.7.1 Edwards Lifesciences Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Percutaneous Coronary Intervention Introduction
      • 12.7.4 Edwards Lifesciences Revenue in Percutaneous Coronary Intervention Business (2014-2019)
      • 12.7.5 Edwards Lifesciences Recent Development
    • 12.8 Acrostak
      • 12.8.1 Acrostak Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Percutaneous Coronary Intervention Introduction
      • 12.8.4 Acrostak Revenue in Percutaneous Coronary Intervention Business (2014-2019)
      • 12.8.5 Acrostak Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualize the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open.
      PCI is used primarily to open a blocked coronary artery and restore arterial blood flow to heart tissue, without requiring open-heart surgery. In patients with a restricted or blocked coronary artery, PCI may be the best option to re-establish blood flow as well as prevent angina (chest pain), myocardial infarctions (heart attacks) and death. Today, PCI usually includes the insertion of stents, such as bare-metal stents, drug-eluting stents, and fully resorbable vascular scaffolds (or naturally dissolving stents).
      In 2018, the global Percutaneous Coronary Intervention market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Percutaneous Coronary Intervention status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Percutaneous Coronary Intervention development in United States, Europe and China.

      The key players covered in this study
      Abbott Vascular
      Svelte Medical
      Medtronic
      Boston Scientific
      Sysmetis
      Cardiac Dimensions
      Edwards Lifesciences
      Acrostak

      Market segment by Type, the product can be split into
      Drug-Eluting Stents
      Bare Metal Stents
      Bioresorbable Stents

      Market segment by Application, split into
      Hospitals
      Healthcare Centers
      Neurological Research Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Percutaneous Coronary Intervention status, future forecast, growth opportunity, key market and key players.
      To present the Percutaneous Coronary Intervention development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Percutaneous Coronary Intervention are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now